Summary
DexCom, Inc. (DXCM) filed its quarterly report on Form 10-Q for the period ended March 31, 2007. As an "accelerated filer," the company provided a snapshot of its financial performance and condition during the first quarter of 2007. While detailed financial statements for the period are included, the filing focuses on the operational and financial health of the company, including its assets, liabilities, and cash flows. Investors should pay close attention to the Management's Discussion and Analysis (MD&A) section for deeper insights into the company's performance drivers and outlook.
Key Highlights
- 1The report covers the quarterly period ended March 31, 2007, providing unaudited financial statements.
- 2DexCom, Inc. is classified as an "accelerated filer," indicating a certain level of financial reporting history and market capitalization.
- 3The filing includes Balance Sheets, Statements of Operations, and Statements of Cash Flows for the relevant periods.
- 4Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is a key section for understanding performance.
- 5Quantitative and Qualitative Disclosures about Market Risk are provided to inform investors of potential financial exposures.
- 6Information regarding Legal Proceedings, Risk Factors, and other material events is presented.
- 7As of April 18, 2007, 28,333,296 shares of common stock were outstanding.
Frequently Asked Questions
This Form 10-Q is a quarterly report filed by DexCom, Inc. with the SEC. It provides an update on the company's financial performance and condition for the three months ended March 31, 2007, including unaudited financial statements and management's discussion of the results.
An "accelerated filer" is a filer that meets certain criteria related to its public float and filing history. It generally means DexCom has a history of timely filings and a significant amount of its stock held by non-affiliates, suggesting a certain level of market maturity.
The "Statements of Operations" within the Financial Statements section will detail the company's revenues and expenses for the three months ended March 31, 2007, and provide a comparison to the same period in 2006. The "Management's Discussion and Analysis of Financial Condition and Results of Operations" will offer narrative context and explanations for these results.
Investors should review "Item 1A. Risk Factors" in Part II of the filing. This section outlines potential risks and uncertainties that could materially affect DexCom's business, financial condition, or results of operations. Specific risks are not detailed in this overview but are crucial for a comprehensive understanding.